Cadrenal Therapeutics
CVKD
#9801
Rank
A$50.27 M
Marketcap
$26.75
Share price
-5.66%
Change (1 day)
93.19%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2024 (TTM): -$10.39

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -$11.48. In 2023 the company made an earnings per share (EPS) of -$15.37.

EPS history for Cadrenal Therapeutics from 2023 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$10.39-32.41%
2023-$15.37